Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2001; 85(01): 190
DOI: 10.1055/s-0037-1612932
DOI: 10.1055/s-0037-1612932
Letters to the Editor
Influence of Fluvastatin alone and in Combination Therapy on C Reactive Protein Levels in Patients with Coronary Artery Disease and Mixed Hyperlipidaemia (FACT Study)
Further Information
Publication History
Received
21 September 2000
Accepted
30 September 2000
Publication Date:
08 December 2017 (online)
-
References
- 1 Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. for the Cholesterol and Recurrent Events (CARE) investigators. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999; 100: 230-5.
- 2 Pauciullo P, Borgnino C, Paoletti R, Mariani M, Mancini M. on behalf of the FACT Study Centers. Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT Study). Atherosclerosis 2000; 150: 429-36.
- 3 Cortellaro M, Cofrancesco E, Boschetti C, Cortellaro F, Mancini M, Mariani M, Paoletti R. on behalf of the Fact Study Centers. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT Study). Thromb Haemost 2000; 83: 549-53.